Your partner for innovative OMICS solutions

90+

Projects completed

190+

Solutions offered to progress research and clinical trials

40+ years

Of experience in sequencing solutions

OHMX.bio applications

Expression analyses

Say goodbye to targeted qPCR data and start seeing the whole picture. RNA sequencing unlocks all expressed genes in a sample. Leveraging various sequencing technologies, our company specializes in uncovering intricate details of gene activity, providing invaluable insights into cellular functions and regulatory mechanisms.

Clinical and research diagnostics

Leverage sequencing to create precise solutions. Trust our deep scientific expertise to help you find your diagnosis or use sequencing as a precise tool to develop panels. Projects are always registered in our quality system.

Quality control of biologics

Aimed at ensuring the integrity and efficacy of biopharmaceutical products. We employ cutting-edge long-read sequencing technology to guarantee the safety of biologics by examining insertion sites, off-target effects or other unwanted aberrations.

Single-cell sequencing

Take your insights to the next level by examining specific cell populations. Single-cell sequencing provides the answer whether your therapy is working in the cells that matter.

OHMX.bio services

We offer a solution to every -omics question. Find out more about the different technologies we can offer, whether for a single question, or a multi-omics approach.

Translatomics

The in-house optimized ribosome profiling service of OHMX.bio allows a genome-wide assessment of the translated portion of the mRNAs. This unravels the translatome in high-throughput, bridging the gap between transcriptomics and proteomics. Our company has tons of experience with this technique, performing your analysis from sample extraction to advanced data analysis and results discussion.

Bioinformatics

Bioinformatics employs a collection of IT algorithms to answer biological questions based on the generated complex omics data. Our team can offer both standard as well as custom developed routines. As such, we work from the raw data towards high-end representations of the results, based on your needs and reported in a clear way.

Epigenomics

In epigenomics, the chemical modifications on top of the genome is analyzed. Epigenetic modifications like DNA methylation are reversible and affect the gene expression, as such having effects in diseases, cancer, As Oxford Nanopore sequences the native DNA, it is the preferable technique for sequencing the genome and in one go epigenome.

Genomics

Genomics involves the analysis of the genome and its variations using high-throughput DNA sequencing techniques. Both a whole-genome or a targeted approach is possible on a broad range of biological and clinical sample types. Given the several advantages it offers, Oxford Nanopore long-read sequencing is most often applied.

Transcriptomics

Proteomics

Proteomics refers to the study of the entire protein set by means of protein purification and identification techniques like mass spectrometry. offers both the data collection and data analysis for the latest state-of-the-art proteomic instruments for the extensive range of flavors that exist in this field.

Why work with OHMX.bio?

Precision through quality

OHMX.bio stands out with its commitment to quality, boasting ISO certification alongside custom quality control steps. We ensure that every result is reliable and meaningful, adhering to rigorous standards to prevent the “garbage in, garbage out” phenomenon.

Tailored personal approach

At OHMX.bio, we believe in the power of personal connection. Our team goes beyond mere transactions, offering face-to-face meetings, personalized assistance, and collaborative brainstorming sessions. We’re not just service providers; we’re partners invested in our clients’ success.

Scientific excellence

OHMX.bio is dedicated to delivering the most scientifically sound solutions. With strong ties to academia, we stay at the forefront of research and technology, ensuring that our clients receive cutting-edge insights and innovative approaches to -omics questions.

Genomics involves the analysis of the genome and its
variations using high-throughput DNA sequencing techniques. Both a whole-genome or a targeted approach is possible on a broad range of biological and clinical sample types. Given the several advantages it offers, Oxford Nanopore long-read sequencing is most often applied.

What our clients say

Thanks to the services of Ohmx.bio, we were able to generate super high quality Ribo-seq data, which we would not have been able to generate ourselves.

We were very well assisted and helped by the expert team of OHMX in our sequencing projects. Definitely when things get challenging (advanced sequencing protocols, low input quantities), the team thrives.

OHMX.bio’s emphasis on data quality control and validation in transcriptomics analysis has earned our trust in their services. Their flexible project approach accommodates additional ad hoc requirements for sequencing and data delivery.

I am very happy with the collaboration with OHMX.bio. They delivered within the agreed timeline, and we got more than we bargained for. The results were well documented, and the study report was directly translatable to the patients and the product we were testing.

Our collaboration with OHMX has been exceptional; their professionalism and efficiency exceeded our expectations. Their knowledgeable team provided timely answers, ensuring seamless communication throughout the project.

Thanks to the services of Ohmx.bio, we were able to generate super high quality Ribo-seq data, which we would not have been able to generate ourselves.

OHMX.bio news & events

Don’t miss out on our latest developments. Interested in meeting us? Check out the events we are attending.

July 13, 2026

Top nanopore sequencing applications in clinical and translational research

Explore how nanopore sequencing accelerates pathogen detection, cancer genomics, rare disease diagnostics and epigenomics in clinical research.

July 8, 2026

Choosing the right biomarker strategy for early-stage clinical trials

Build a biomarker strategy early clinical trials teams can use for Phase I/II trials: roles, enrichment, assay validation, sampling plans, and decision-making frameworks.